InspireMD


TEL AVIV, Israel, March 2, 2011 - InspireMD (www.inspire-md.com/site_en/), developer of the MGuard(TM) net protective stent system ( www.inspire-md.com/site_en/mguard/the-technology/), has expanded its MGuard production facilities to meet the steady increase in demand.

TEL AVIV, Israel, December 17, 2010 - InspireMD, developer of the novel MGuard(TM), a combination of a coronary stent merged with an embolic protection specifically designed for Acute MI (AMI) patients, received significant exposure at the ICI, Innovations in Interventional Cardiology, meeting this week in Tel-Aviv.

TEL AVIV, Israel, September 9, 2010 - InspireMD Ltd., a medical device company engaged in the development and commercialization of the mesh based MGuard(TM) stent systems, is proud to report that mesh-based protection, is now recommended for use in the new Guidelines of the Task force of Myocardial Revascularization of the European Society of Cardiology (ESC).
Older News
S M T W T F S
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 1 2 3 4 5
Copyright© 2011 The Gaea Times